Return to Listing

1 result(s) for Midostaurin (PKC412)

PI Name Protocol # Title
Richard Maziarz IRB00009571 A Phase II, randomized, comparative trial of standard of care, with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplantation in patients with FLT3-ITD mutated acute myeloid leukemia
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080

You may qualify for additional trials within our Phase 1 Program